Tuesday, April 2, 2019

New purchase : Abbvie Inc.

New position started in the porfolio. Purchased 6 shares of Abbvie Inc (NYSE:ABBV) at $80.54 per share. Abbvie pays dividends with 2-5-8-11 schedule and my starting yield of cost is at 5.30%

AbbVie Inc. (AbbVie), incorporated on April 10, 2012, is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products.

No comments:

Post a Comment